Comparison results
| Results: Differences General | ✘Tumors of the lacrimal glands | ✘Leaf-shaped breast tumor | |||||||||||||
| Related research | Analogs | Analogs | |||||||||||||
| |||||||||||||||
| Distinctive symptoms | |||||||||||||||
| Register, to see more distinctive signs of diseases and studies | 98% | — | |||||||||||||
| Register, to see more distinctive signs of diseases and studies | — | 100% | |||||||||||||
| tumors of the lacrimal glands | 85% | — | |||||||||||||
| fibroma | — | 93% | |||||||||||||
| has a swelling of the eye | 80% | — | |||||||||||||
| breast tumor | — | 89% | |||||||||||||
| malignant arterial hypertension | 80% | — | |||||||||||||
| solid tumor | — | 85% | |||||||||||||
| exophthalmos | 71% | — | |||||||||||||
| mastectomy | — | 85% | |||||||||||||
| glaucoma | 65% | — | |||||||||||||
| benign tumors of the mammary glands | — | 80% | |||||||||||||
| does not like touching | 63% | — | |||||||||||||
| history of chest surgery | — | 74% | |||||||||||||
| does not tolerate pain | 55% | — | |||||||||||||
| nodular mastopathy | — | 71% | |||||||||||||
| hypertension | 50% | — | |||||||||||||
| nodular neoplasms of the thyroid gland | — | 67% | |||||||||||||
| increased | 43% | — | |||||||||||||
| nipple discharge | — | 65% | |||||||||||||
| oncology | 100% | 62% | |||||||||||||
| fibroadenoma of the breast | — | 64% | |||||||||||||
| benign epithelial tumors | 73% | 45% | |||||||||||||
| thyroid atrophy | — | 64% | |||||||||||||
| vascular tumor | 53% | 33% | |||||||||||||
| excess progesterone | — | 60% | |||||||||||||
| leaf-shaped breast tumor | — | 58% | |||||||||||||
| thyroid adenoma | — | 57% | |||||||||||||
| pain in the nipples | — | 55% | |||||||||||||
| progesterone deficiency | — | 54% | |||||||||||||
| breast sarcoma | — | 52% | |||||||||||||
| sebaceous gland adenoma | — | 52% | |||||||||||||
| liver is indurated | — | 50% | |||||||||||||
| cystic mastopathy | — | 50% | |||||||||||||
| thyroid nodes | — | 50% | |||||||||||||
| mastopathy | — | 50% | |||||||||||||
| tumors of the sebaceous glands | — | 50% | |||||||||||||
| diffuse mastopathy | — | 50% | |||||||||||||
| fibrous mastopathy | — | 50% | |||||||||||||
| thyroid cancer | — | 49% | |||||||||||||
| adrenal hyperplasia | — | 48% | |||||||||||||
| pituitary tumors | — | 46% | |||||||||||||
| tumors of the adrenal glands | — | 45% | |||||||||||||
| hormonal disorders | — | 44% | |||||||||||||
| lactation problems | — | 43% | |||||||||||||
| consequences of abortion | — | 42% | |||||||||||||
| liver cancer | — | 42% | |||||||||||||
| hepatosis fatty | — | 42% | |||||||||||||
| violation of fat metabolism | — | 41% | |||||||||||||
| liver atrophy | — | 41% | |||||||||||||
| hepatosis | — | 41% | |||||||||||||
| lactation | — | 40% | |||||||||||||
| enlargement of the thyroid gland | — | 38% | |||||||||||||
| pituitary gland diseases | — | 37% | |||||||||||||
| abortions | — | 37% | |||||||||||||
| lymphosarcoma | — | 36% | |||||||||||||
| thyroid diseases | — | 36% | |||||||||||||
| pain chest | — | 33% | |||||||||||||
| diabetes mellitus | — | 32% | |||||||||||||
| acute condition | — | 32% | |||||||||||||
| liver problems | — | 31% | |||||||||||||
| imbalance | — | 31% | |||||||||||||
| роды и вскармливание | — | 30% | |||||||||||||
| mammary gland hypoechoic | — | 26% | |||||||||||||
| thyroid cancer in pregnant women | — | 26% | |||||||||||||
| mammary gland anechoic | — | 26% | |||||||||||||
| history of surgery | 43% | 59% | |||||||||||||
| benign neoplasms | 54% | 58% | |||||||||||||
| cancer | 49% | 52% | |||||||||||||
Instructions
Video 
- Introduce new diseases through 🔍 Search and input on the top panel using
- The table shows the most important distinguishing symptoms, tests and diagnoses related to the selected diseases.
- The higher the percentage, the more important this symptom is for the disease and vice versa. At 0%, we can say that this symptom never occurs in the disease.
- The list changes dynamically depending on the data of the current visit in the selection of therapy .
- Click on the percentageto see the suggestions from the original source.
- By using the service, you agree to user agreement.
